Advanced Therapies Week 2022 | The past, present and future of AAV vectors

Nathalie Clement, PhD, Unicorn Consultations, Gainesville, FL, provides an overview of her experiences working with adeno-associated viral (AAV) vectors, from its infancy of the field to the present day, where clinical trials are being conducted to assess AAV-based therapies. Dr Clement additionally highlights the growth of the AAV vector field and the increased demand for treatments, as well as the history of AAV vector research. This interview took place at Advanced Therapies Week 2022.